↓ Skip to main content

Dove Medical Press

Effects of multiple-dose ponesimod, a selective S1P1 receptor modulator, on lymphocyte subsets in healthy humans

Overview of attention for article published in Drug Design, Development and Therapy, December 2016
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter
1 X user
patent
5 patents

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
18 Mendeley
Title
Effects of multiple-dose ponesimod, a selective S1P1 receptor modulator, on lymphocyte subsets in healthy humans
Published in
Drug Design, Development and Therapy, December 2016
DOI 10.2147/dddt.s120399
Pubmed ID
Authors

Stipo Jurcevic, Pierre-Eric Juif, Colleen Hamid, Roseanna Greenlaw, Daniele D’Ambrosio, Jasper Dingemanse

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 33%
Student > Ph. D. Student 2 11%
Student > Bachelor 1 6%
Student > Master 1 6%
Student > Postgraduate 1 6%
Other 0 0%
Unknown 7 39%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 17%
Neuroscience 2 11%
Medicine and Dentistry 2 11%
Business, Management and Accounting 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Other 2 11%
Unknown 7 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2024.
All research outputs
#7,363,939
of 25,394,764 outputs
Outputs from Drug Design, Development and Therapy
#487
of 2,270 outputs
Outputs of similar age
#122,724
of 416,622 outputs
Outputs of similar age from Drug Design, Development and Therapy
#12
of 42 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 2,270 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 416,622 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.